Skip to main content
Clinical Trials/NCT01171248
NCT01171248
Completed
Not Applicable

Central and Peripheral 24h BP and the Association to Autonomic Neuropathy and Diabetic Nephropathy in Type 1 Diabetic Patients

Steno Diabetes Center Copenhagen1 site in 1 country650 target enrollmentSeptember 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 1 Diabetes
Sponsor
Steno Diabetes Center Copenhagen
Enrollment
650
Locations
1
Primary Endpoint
Ambulatory blood pressure (AMBP)
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The aim of the study is to evaluate the prevalence of abnormal nocturnal blood pressure (BP) in patients with type 1 diabetes. The investigators wish to gain knowledge on the relation between central and peripheral 24 hour BP and a possible association to late complications in diabetes.

Registry
clinicaltrials.gov
Start Date
September 2009
End Date
August 2011
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Peter Rossing

Senior Physician, DMSc

Steno Diabetes Center Copenhagen

Eligibility Criteria

Inclusion Criteria

  • Type 1 diabetes
  • more than 18 years of age

Exclusion Criteria

  • End Stage Renal Disease (ESRD)
  • other kidney disease than diabetic nephropathy

Outcomes

Primary Outcomes

Ambulatory blood pressure (AMBP)

Time Frame: 2 years

The participants are seen once (cross-sectional) and we measure AMBP in order for us to investigate any association between AMBP and other parameters such as age, duration of diabetes, albuminuria status and other diabetic complications.

Secondary Outcomes

  • Diabetic late complications(2 years)

Study Sites (1)

Loading locations...

Similar Trials